Phill leads competitive & market intelligence at ThirtyFiveBio, and provides commercial strategy & business development support. He is also the Business Analyst for the M:M Bio ecosystem, covering GreyWolf Therapeutics and Pathios Therapeutics. Phill brings nearly 10 years of commercial experience working in business development, sales, and product management roles. Prior to joining ThirtyFiveBio, his backgrounds spanned healthcare consulting, digital tech product management, and various commercial disciplines across large multi-nationals. He has always been passionate about supporting science commercially, and has previously founded a company supporting scientists to gain access to emerging alternative funding sources in North America. Originally from New Zealand, Phill holds an MBE (Bioscience Enterprise) from the University of Cambridge, and BSCs from the University of Otago in Chemistry and Business.